Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009
by Amylin Pharmaceuticals, LLC..
Recruitment status was Active, not recruiting
Study NCT00819234 Information provided by Amylin Pharmaceuticals, LLC.
First Received on December 24, 2008. Last Updated on January 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Signs and Symptoms
Interventions listed in this trial
Pramlintide and Metreleptin
Additional drug interventions recognized in this trial
Islet Amyloid Polypeptide
More general drug interventions related to this trial
Central Nervous System Agents
Physiological Effects of Drugs
Sponsors listed in this trial
Amylin Pharmaceuticals, LLC.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers